PFIZER-BioNTech COVID-19 BOOSTER APPROVED

Dec 09, 2022

By Angus Gillespie

Share on

Health Canada has approved a Pfizer-BioNTech COVID-19 vaccine booster for use in children ages five to 11.

The vaccine targets both the original strain of the coronavirus and more recent variants.

Health Canada says in a press release that after the thorough review, it has found the vaccine is safe and effective and that its benefits outweigh any potential risks when used as a booster dose.

The National Advisory Committee on Immunization strongly recommends children with weakened immune systems or underlying medical conditions be offered a dose of the new vaccine at least six months after they receive their first two COVID-19 shots.

The recommendation for other children in the age group is more discretionary, and NACI suggests the bivalent booster “may be” offered.

For now, only one COVID-19 booster shot is recommended for all kids in the five to 11 age category.

Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: